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The new millennium is witness to astonishing devel-
opments in technology that have expanded our horizon
in Ophthalmology. The potential for breakthrough
advances to have an impact on the enigmatic and
incurable retinal and neural disorders is now very real.
With thousands of scientists involved in putting
together various pieces of the puzzle, our newly
diagnosed patients with a little-understood retinal or
neural disease may feel some optimism about seeing
some effective treatment within their lifetimes. Visual
electrophysiology is an integral tool in the endeavour to
understand and characterize the physiological basis for
such disorders. Updating ourselves is a prerequisite to
providing cutting-edge care to our patients.
In this rapidly expanding field involving diverse
disciplines, it is not easy to follow or to understand the
scope of information only from published literature or
from the ubiquitous Internet. Scientific meetings pro-
vide a wonderful opportunity to interact and network
with inquisitive minds. This issue of Documenta
Ophthalmologica brings to you the abstracts of scien-
tific presentations of the 45th International Symposium
of the Society for Clinical Electrophysiology of Vision
(ISCEV). Our society was founded in 1958 (under its
former name, ISCERG) to underpin the advances in
electroretinography, the first physiological technique to
be widely applied in clinical ophthalmology. ISCEV
now has a well-established tradition as a forum to learn,
share and bring together masters and students across
the whole field of clinical electrophysiology of vision
in an especially congenial and informal environment.
For the first time, the symposium is being held in the
large Indian subcontinent. This is a golden opportunity
for colleagues to participate, particularly for those who
have fewer, and much more expensive, opportunities to
attend international conferences of this calibre.
This year there are two special themes focused on
neuro-ophthalmolgy and on retinal dystrophies as
well as a special session of invited speakers focusing
on the ERG in drug development.
In neuro-ophthalmology, VEPs are used primarily
to probe visual function at the level of the visual
cortex providing important information regarding the
functional integrity of the visual system. Basic
functions can be assessed by conventional flash and
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pattern VEPs. Recent advances, for example, multi-
focal VEPs, multi channel VEP, motion VEP and
sweep VEPs have enabled us to devise more specific
tests of visual function and to improve the localiza-
tion and detection of VEP signals. The Symposium
theme, ‘‘the evolving role of VEPs in neuro-ophthal-
mology’’, celebrates the impact of electrophsyiologic
innovations on clinical and basic research of neuro-
ophthalmology.
Over the last three decades there have been rapid
advances in the understanding of the genetic basis of
retinal disorders. Since the mapping of the first gene
for X-linked RP in 1984, over a 100 genes for a range
of retinal disorders have now been characterized.
There are more genes yet to be identified since the
known ones do not account for all affected families.
This high degree of heterogeneity, both genetic and
clinical, has rendered it very challenging to harness
molecular genetic information towards benefits for
patients. One aspect of defining retinal disorders from
a molecular genetic standpoint is to explore whether
specific gene mutations are associated with a distinc-
tive set of manifestations of the disease—specifically,
is there correlation between genotype and phenotype?
Such correlations, if sufficiently specific, may serve
as indicators of disease prognosis for a patient with a
particular genotype. As a sensitive indicator of retinal
function, electrophysiology forms an integral part of
the definition of the phenotype and can provide
insight into the pathophysiologic mechanism for
specific genes. ERGs serve to define the extent of
phenotypic variability or heterogeneity associated
with a specific gene, to confirm the nature of
functional differences underlying clinical heteroge-
neity and to provide an indication of early or mild
forms of disease in mutation carriers. Some genetic
mutations cause regional differences in retinal func-
tion that may be identified by multifocal ERGs. Thus,
this technique offers the potential improved prognos-
tic information when considered with specific geno-
types. The Symposium theme, ‘‘the role of ocular
electrophysiology in genotype–phenotype correla-
tion’’ focuses on the rapid developments in genetic
retinal disease.
While there may be potential for widespread genetic
cures in medicine in the near future, current advances
rely heavily on the unprecedented acceleration in
new drug development. Each new drug requires thor-
ough evaluation of both its safety and its efficacy.
Neuro-toxicity can be particularly difficult to detect.
The retina is a highly sensitive and accessible neural
tissue with exquisite neuropiles oriented to produce
large and specific electrophysiologic signals, ERGs.
The special session, ‘‘the ERG in pre-clinical and
clinical drug development’’ explores the role of the ERG
for drug testing in both human and animal trials.
However, the varied menu over five days goes
beyond the focused themes. Looking to the future,
Prof. Sumantra Chattarji’s invited introductory
lecture updates us on ‘The Changing Brain: How
visual and other behavioural experiences influence
the brain.’’ In addition, the programme includes a
variety of free papers, dedicated poster sessions and a
clinical cases session. A highlight of Symposium, the
2007 Adachi Award Lecture by Prof. Eberhard
Zrenner, ‘New Potentials for Restoring Neuroretinal
Function’ gives us a view into the future by reporting
the cutting edge developments of retinal implants for
human applications.
The Symposium deliberations are a wonderful
opportunity for a wide audience who have had
limited exposure to these engaging techniques: tech-
niques that are often the tools to unlock mysteries of
signs and symptoms that baffle us during patient care.
The ISECV abstracts in this issue involve ophthal-
mologists, neurologists, neurobiologists, pharmacol-
ogists, optometrists, vision scientists, molecular
geneticists, and students from related specialties.
The icing on the cake is a two days pre-conference
hands-on ISCEV Educational Course taught by
distinguished members of the society. A bonus is
the trade exhibition involving all major electrodiag-
nostic equipment manufacturers of the world!
The 45th ISCEV symposium is organized by L V
Prasad Eye Institute in Hyderabad, India, which
brought advanced clinical electrophysiology to a
country that has, on one hand, the largest number of
blind people in the world and, on the other hand, the
very first National Programme to control blindness!
The symposium is expected to be an enriching
academic and social opportunity having an interna-
tional aura with traditional Indian flavour!
Editorial note: The abstracts in this issue have been
edited and re-set to a standard format. We have made
every effort to respect the intended meaning of the
originals ands apologise for any inadvertent misin-
terpretation.
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